Parsatuzumab (Synonyms: Anti-EGFL7; RG 7414) |
| Katalog-Nr.GC69662 |
Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody that binds to EGFL7 as an immune modulator. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, which may inhibit angiogenesis and reduce vascular endothelial growth factor (VEGF) inhibition.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1312797-14-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Parsatuzumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Parsatuzumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *